» Articles » PMID: 19609461

The Role of X-box Binding Protein-1 in Tumorigenicity

Overview
Publisher Thomson Reuters
Specialty Pharmacology
Date 2009 Jul 18
PMID 19609461
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Rapid growth of a tumor can overwhelm the vasculature that supplies it with nutrients and oxygen. Inside such tumors, cells undergo endoplasmic reticulum stress but can survive such adverse microenvironments by an adaptive mechanism called the unfolded protein response (UPR). X-box binding protein-1 (XBP-1) is a critical transcriptional activator of the UPR and is responsible for regulating the function of genes in cell survival. An unconventional splicing of the XBP-1(U) messenger RNA (mRNA) results in two proteins: XBP-1(S) that is often increased in a variety of human cancers and any translated proteins from the unspliced XBP-1(U) mRNA that acts as a dominant negative of endogenous XBP-1(S) action. In cancer cells, overexpression of XBP-1 can confer drug resistance by preventing drug-induced cell-cycle arrest and mitochondrial permeability and apoptosis, while downregulation of XBP-1 increases the sensitivity to killing by hypoxia. XBP-1 is also implicated in cellular de-differentiation, oncovirus infection and the epithelial-to-mesenchymal transition. Given that XBP-1 mediates a wide range of responses in tumorigenesis, it is logical to focus on XBP-1 as an anticancer therapeutic target. Furthermore, combining inhibitors of XBP-1 with other anti-UPR drugs may enhance the activity of some antineoplastic therapies.

Citing Articles

Brain-targeted delivery of neuroprotective survival gene minimizing hematopoietic cell contamination: implications for Parkinson's disease treatment.

Lee M, Kang S, Um K, Lee S, Hwang H, Baek K J Transl Med. 2024; 22(1):53.

PMID: 38218903 PMC: 10790275. DOI: 10.1186/s12967-023-04816-x.


Mechanism and Role of Endoplasmic Reticulum Stress in Osteosarcoma.

Zhu P, Li T, Li Q, Gu Y, Shu Y, Hu K Biomolecules. 2022; 12(12).

PMID: 36551309 PMC: 9775044. DOI: 10.3390/biom12121882.


The unfolded protein response (UPR) pathway: the unsung hero in breast cancer management.

Patra A, Adhikary A, Ghosh S Apoptosis. 2022; 28(3-4):263-276.

PMID: 36536258 DOI: 10.1007/s10495-022-01803-3.


TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.

Gao W, Zhang Z, Wang H, Li X, Peng W, Guan H Front Genet. 2022; 13:895281.

PMID: 35754792 PMC: 9214264. DOI: 10.3389/fgene.2022.895281.


Unravel the molecular mechanism of XBP1 in regulating the biology of cancer cells.

Shi W, Chen Z, Li L, Liu H, Zhang R, Cheng Q J Cancer. 2019; 10(9):2035-2046.

PMID: 31205564 PMC: 6548171. DOI: 10.7150/jca.29421.


References
1.
Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson C . Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004; 6(12):1221-8. DOI: 10.1038/ncb1192. View

2.
Ma Y, Hendershot L . The unfolding tale of the unfolded protein response. Cell. 2002; 107(7):827-30. DOI: 10.1016/s0092-8674(01)00623-7. View

3.
Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K . Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol. 2003; 38(5):605-14. DOI: 10.1016/s0168-8278(03)00029-1. View

4.
Zhivotovsky B, Kroemer G . Apoptosis and genomic instability. Nat Rev Mol Cell Biol. 2004; 5(9):752-62. DOI: 10.1038/nrm1443. View

5.
Riggins R, Bouton A, Liu M, Clarke R . Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. Vitam Horm. 2005; 71:201-37. DOI: 10.1016/S0083-6729(05)71007-4. View